Jun 11, 2020 / 02:00PM GMT
David S. Kabakoff - NextCure, Inc. - Independent Chairman of the Board
Good morning, and welcome to the 2020 Annual Meeting of the Stockholders of NextCure, Inc., our first annual meeting as a public company.
I'm David Kabakoff, Chair of the Board of Directors of NextCure. We're holding this meeting virtually over the Internet in order to ensure that the health and welfare of our stockholders, directors and management in the light of the COVID pandemic and to enable us to reach more stockholders and make it easier for them to participate than would be the case with an in-person meeting.
To all of our stockholders, I wish the best for you, your families and your communities in these unprecedented times. There are 2 items of business on today's agenda: first, the election of Class I directors; and second, the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2020.
I will act as the chair of the meeting. (Operator Instructions) In addition, after the business portion of the meeting, we will answer
NextCure Inc Annual Shareholders Meeting Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers